Get the app
USHealthcare

Cronos Group Inc (CRON)

US · Healthcare · Drug Manufacturers - Specialty & Generic

$3.37+2.43%
Last close · 2026-09-17

Latest quarter · ended 2026-06-30

Revenue
$70.6M
Revenue YoY
+111.0%
Net profit
$32.1M
EPS
$0.03
EPS estimate
$0.01
Net margin
45.4%

EPS came in at 0.03 against a street estimate of 0.01 — a beat of 200.0%.

Key statistics

Market cap
$1.16B
P/E
16.5
Forward P/E
26.0
P/B
1.08
Book value
$2.88
EPS (TTM)
$0.19
52-week high
$3.61
52-week low
$2.28
50-day MA
$3.03
200-day MA
$2.75
Beta
1.28

Analyst view

Analysts rate Cronos Group Inc a hold (2 buy, 2 hold, 1 sell out of 5) with an average price target of $2.53.

Shareholding

Insiders
49.14%
Institutions
15.46%

Largest institutional holders

FundStake
D. E. Shaw & Co LP2.40%
Chescapmanager LLC2.16%
Tidal Investments LLC.1.09%
Dimensional Fund Advisors, Inc.0.83%
Renaissance Technologies Corp0.55%
Springbok Capital Management, LLC0.41%
CIBC World Markets Inc.0.37%
Susquehanna International Group, LLP0.34%

Recent filings & reports

DocumentDate
Material agreement · Q3 2026
CRONOS GROUP INC. - FORM 8-K SUMMARY HEADLINE NUMBERS • Company: Cronos Group Inc., British Columbia, Canada; trades as CRON on NASDAQ • Filing Date
2026-09-11
Quarterly report · Q2 2026
CRONOS GROUP INC. - Q2 2026 10-Q SUMMARY HEADLINE NUMBERS • Net Revenue (Q2 2026): $53.0 million (Q2 2025: $33.5 million) – up 58% year-over-year •
2026-08-06
Results announced · Q3 2026
CRONOS GROUP Q2 2026 RESULTS SUMMARY HEADLINE NUMBERS • Net revenue Q2 2026: $53.0 million, up 58% year-over-year (51% organic, constant-currency ba
2026-08-06
Shareholder vote results · Q2 2026
CRONOS GROUP INC. – FORM 8-K SUMMARY HEADLINE NUMBERS • Annual Meeting of Shareholders held June 18, 2026 • Total votes cast for director elections:
2026-06-22
Quarterly report · Q1 2026
CRONOS GROUP INC. – Q1 2026 10-Q SUMMARY HEADLINE NUMBERS • Net revenue (after excise taxes): $45.2 million for Q1 2026, up 40% from $32.3 million i
2026-05-11
Results announced · Q2 2026
CRONOS GROUP Q1 2026 RESULTS SUMMARY HEADLINE NUMBERS • Net revenue increased 40% year-over-year to $45.2 million in Q1 2026 (vs. $32.3 million in Q
2026-05-11
Proxy statement · Q4 2025
CRONOS GROUP INC. – 2026 PROXY STATEMENT SUMMARY WHAT SHAREHOLDERS ARE VOTING ON • Proposal 1 (Director Election): Elect seven directors by pluralit
2026-04-24
Annual report FY2025
CRONOS GROUP INC. — 2025 ANNUAL REPORT SUMMARY HEADLINE NUMBERS • Market Capitalization (as of June 30, 2025): $379.9 million (calculated at $1.91 p
2026-02-26

Readable in the app.

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Cronos Group Inc — free to start.

Google PlayApp Store

Other Healthcare companies

Data updated 2026-09-18.